The EU Vaccine Industry in Figures

Europe is at the heart of global vaccine research and production. Most of the activities of the major innovative Vaccines Europe members research based-companies are based in the region.

Find out more

Vaccines: a tool for spending smart

Effective vaccination programmes ease pressure on budgets and allow resources to focus on other healthcare areas and medical innovation

Find out how

-->

Prevention First

Vaccination at the Heart of Public Health. Vaccines Europe calls on EU policy-makers to develop a comprehensive vaccination strategy through five core policy asks.

Read more

Vaccine Market Access in the EU

How long for a vaccine to reach European Population? 6,4 years is the median time lag between marketing authorisation and effective population access

Find out more

An industry for healthy lives

As the EU-wide recognised vaccine industry stakeholder, Vaccines Europe represents major innovative research-based vaccine companies operating in Europe as well as small and medium sized enterprises.
Find out more about our services, the opportunites we offer and how to become a member.

Find out how to become a member

Latest News

RSS

Council Conclusions on one health approach to combat AMR

2016 06 22 Written by Vaccines Europe

Vaccines Europe welcomes the EU Health Council adoption of the Council Conclusions on the next steps under a one health approach to combat antimicrobial resistance. Vaccines Europe believes that a holistic approach that takes into account alternative approaches which can reduce the use of antibiotics should be considered as part of a long term strategy to combat this global public health issue. The Council Conclusions call upon the Member States to “encourage the use of alternative treatment and prevention options including vaccines and the development and use of affordable diagnostics tests in human and veterinary medicine“, which is in line with recent evidence that suggests that antibiotic use can decrease in association with the initiation of immunisation programmes or increased uptake of available vaccines. The Vaccines Europe members are committed to this global health issue by investing in the development of vaccines that target resistant bacteria that causes healthcare associated infections, such as Staphylococcus aureus and Clostridium difficile which would play a crucial role in tackling drug resistance.

Find here a draft Vaccines Europe paper on the Role of vaccination in reducing antimicrobial resistance.

From vaccines shortages to sustainable vaccine supply

2016 06 07 Written by Vaccines Europe

Europe has been a long-standing leader in vaccines. Maintaining this position and ensuring vaccine availability in times of increased demand and supply constraints can only be achieved by a strong industry operating in a stable environment, able to produce vaccines of the highest quality and to innovate to meet future vaccine needs.

In the light of achieving these goals, Vaccines Europe issued a position paper on the topic of vaccine shortages, which can be accessed on this link.

European Immunisation Week: a call for EU political commitment on immunisation

2016 04 24 Written by Vaccines Europe

On 24–30 April 2016, Europe celebrates the European Immunization Week with the aim of increasing vaccination coverage by raising awareness of the importance of immunisation among parents and caregivers, health care professionals, policy- and decision-makers, and the media.

This week should give us the opportunity to raise the importance of immunisation as a critical public health intervention and the value that immunisation represents in terms of health and economic returns,” said the Vaccines Europe president, Andrea Rappagliosi. “And in this respect we would like to see more activities organised at EU and national level during European Immunization Week.”

Read more…

See all News